133 related articles for article (PubMed ID: 25412645)
1. Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo.
Wyche TP; Dammalapati A; Cho H; Harrison AD; Kwon GS; Chen H; Bugni TS; Jaskula-Sztul R
Cancer Gene Ther; 2014 Dec; 21(12):518-25. PubMed ID: 25412645
[TBL] [Abstract][Full Text] [Related]
2. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
4. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.
Nakakura EK; Sriuranpong VR; Kunnimalaiyaan M; Hsiao EC; Schuebel KE; Borges MW; Jin N; Collins BJ; Nelkin BD; Chen H; Ball DW
J Clin Endocrinol Metab; 2005 Jul; 90(7):4350-6. PubMed ID: 15870121
[TBL] [Abstract][Full Text] [Related]
5. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.
Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H
Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.
Pinchot SN; Jaskula-Sztul R; Ning L; Peters NR; Cook MR; Kunnimalaiyaan M; Chen H
Cancer; 2011 Apr; 117(7):1386-98. PubMed ID: 21425138
[TBL] [Abstract][Full Text] [Related]
7. Hesperetin, a potential therapy for carcinoid cancer.
Zarebczan B; Pinchot SN; Kunnimalaiyaan M; Chen H
Am J Surg; 2011 Mar; 201(3):329-32; discussion 333. PubMed ID: 21367373
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.
Somnay Y; Simon K; Harrison AD; Kunnimalaiyaan S; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2013 Jan; 24(1):66-72. PubMed ID: 23147412
[TBL] [Abstract][Full Text] [Related]
9. Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines.
Mokhtari RB; Kumar S; Islam SS; Yazdanpanah M; Adeli K; Cutz E; Yeger H
BMC Cancer; 2013 Aug; 13():378. PubMed ID: 23927827
[TBL] [Abstract][Full Text] [Related]
10. Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells.
Kunnimalaiyaan M; Traeger K; Chen H
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G636-42. PubMed ID: 16160079
[TBL] [Abstract][Full Text] [Related]
11. Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.
Kunnimalaiyaan M; Yan S; Wong F; Zhang YW; Chen H
Surgery; 2005 Dec; 138(6):1137-42; discussion 1142. PubMed ID: 16360401
[TBL] [Abstract][Full Text] [Related]
12. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells.
Van Gompel JJ; Kunnimalaiyaan M; Holen K; Chen H
Mol Cancer Ther; 2005 Jun; 4(6):910-7. PubMed ID: 15956248
[TBL] [Abstract][Full Text] [Related]
13. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Cao Y; Yu L; Dai G; Zhang S; Zhang Z; Gao T; Guo W
Eur J Pharmacol; 2017 Jan; 794():77-84. PubMed ID: 27845066
[TBL] [Abstract][Full Text] [Related]
14. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.
Gu Y; Xiao L; Ming Y; Zheng Z; Li W
Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808
[TBL] [Abstract][Full Text] [Related]
15. Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer models.
Zhang CC; Pavlicek A; Zhang Q; Lira ME; Painter CL; Yan Z; Zheng X; Lee NV; Ozeck M; Qiu M; Zong Q; Lappin PB; Wong A; Rejto PA; Smeal T; Christensen JG
Clin Cancer Res; 2012 Sep; 18(18):5008-19. PubMed ID: 22806875
[TBL] [Abstract][Full Text] [Related]
16. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
[TBL] [Abstract][Full Text] [Related]
17. MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
Chen JY; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Jan; 158(1):15-9. PubMed ID: 19765735
[TBL] [Abstract][Full Text] [Related]
18. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid.
Pfragner R; Behmel A; Höger H; Beham A; Ingolic E; Stelzer I; Svejda B; Moser VA; Obenauf AC; Siegl V; Haas O; Niederle B
Anticancer Res; 2009 Jun; 29(6):1951-61. PubMed ID: 19528452
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells.
von Wichert G; Jehle PM; Hoeflich A; Koschnick S; Dralle H; Wolf E; Wiedenmann B; Boehm BO; Adler G; Seufferlein T
Cancer Res; 2000 Aug; 60(16):4573-81. PubMed ID: 10969809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
